U.S. Electrical Stock News

Viking Therapeutics (NasdaqCM:VKTX) has completed patient enrollment in its Phase 3 VANQUISH-2 trial for VK2735. The trial is evaluating VK2735, a dual GLP-1/GIP agonist, in obesity and type 2 diabetes. This milestone moves VK2735 further along Viking's clinical development path as of 2026. For you as an investor, the VANQUISH-2 enrollment milestone puts fresh attention on Viking Therapeutics, a clinical-stage company focused on metabolic and endocrine diseases. VK2735 sits within the...

Wondering whether SailPoint at US$12.28 is starting to look interesting or still too expensive for the risk you are taking. The stock has been under pressure, with a 0.5% decline over the last 7 days, 6.4% over the last month, and a year to date return of 35.2% and 40.2% over the past year. These moves are occurring as the market continues to reassess software names and focus more closely on business quality, balance sheet strength, and cash generation. For SailPoint, this context matters...

In March 2026, Organic Payment Gateways announced it now provides tested, specialized credit card processing integrations for Farm Bill-compliant US cannabis seed businesses using Wix e-commerce sites, bypassing restrictions from mainstream processors like Wix Payments, Stripe, and PayPal. The integrations pair high-risk-friendly merchant accounts with Authorize.Net and third-party carts while preserving existing Wix store designs, potentially making Wix a more practical option for regulated...

Wondering whether Western Alliance Bancorporation at around US$70 a share looks attractively priced or not? This article breaks down what the current valuation really implies for you as a shareholder or potential investor. The stock has moved 4.2% over the last week, while sitting on a 20.5% decline over 30 days and a 17.9% decline year to date, with an 8.2% decline over the last year and a very large 3 year return of around 2x. These swings have kept Western Alliance in the headlines, with...

Primerica stock snapshot after recent performance Primerica (PRI) has caught investor attention after mixed recent returns, with the stock roughly flat over the past month, a modest gain over the past week, and a negative total return over the past year. See our latest analysis for Primerica. At a share price of $253.69, Primerica has seen short term share price momentum cool, while the 1 year total shareholder return of 11.05% decline contrasts with 3 and 5 year total returns of 56.70% and...

If you are wondering whether American Public Education at about US$57.42 still offers value or has run too far ahead of itself, you are not alone. The stock has posted returns of 5.3% over 7 days, 26.3% over 30 days, 58.8% year to date and 148.2% over 1 year. Over 3 years the gain is around 11x and over 5 years it is 58.2%. Recent coverage around American Public Education has focused on how the business is positioned within the Consumer Services sector and how its model responds to changing...

Parker-Hannifin Corporation recently disclosed that long-serving director Kevin A. Lobo will not stand for reelection at the 2026 Annual Meeting, following his election to the Board of GE HealthCare Technologies, although he will remain on Parker-Hannifin’s Board until his current term ends. This leadership change comes as Parker-Hannifin’s Aerospace Systems segment reports record quarterly revenue and operating margins supported by a multi-billion-dollar backlog, highlighting both...

If you are wondering whether IDEXX Laboratories at around US$573 per share still makes sense for your portfolio, the key question is what you are actually paying for the underlying business. The stock has delivered a 35.7% return over the last year, even as the share price shows a 1.1% decline over 7 days, an 11.7% decline over 30 days, and a 14.4% decline year to date. These shifts can change how investors think about both upside and risk. Recent coverage has focused on IDEXX Laboratories...

Index inclusion puts EMCOR Group (EME) on more investors’ radar EMCOR Group (EME) was added to the FTSE All-World Index in March 2026. This inclusion can attract fresh demand as index funds and institutional investors adjust their holdings. See our latest analysis for EMCOR Group. Despite a recent 1-day share price decline of 5.03% and a 30-day share price decline of 9.98% to US$726.31, EMCOR’s 1-year total shareholder return of 91.87% and 5-year total shareholder return of about 5.5x suggest...

In February 2026, Raymond James upgraded The Baldwin Insurance Group Inc. to a strong Buy rating after the company delivered its sixth consecutive year of leading industry organic growth, margin expansion, and robust adjusted diluted earnings per share. At the same time, Baldwin Insurance Group authorized a US$250,000,000 share repurchase program over the next 12 months, signaling management’s confidence in the business and capital allocation priorities. We’ll now examine how Baldwin...

Q4 Earnings Put Elevance Health (ELV) in Focus Elevance Health (ELV) moved back into the spotlight after reporting fourth quarter and full-year 2025 results, highlighting Medicaid and Medicare Advantage pressures alongside Health Benefits revenue growth and a 2026 adjusted EPS target of at least $25.50. See our latest analysis for Elevance Health. At a share price of US$294.25, Elevance Health has seen a 10.05% 1 month share price decline and a 16.94% year to date share price decline, while...

Dividend decision and what it means for investors Coca-Cola FEMSA. de (NYSE:KOF) shareholders have approved a cash dividend of MXN 0.9675 per share for fiscal 2025, to be paid in four equal installments across April, July, October, and December 2026. Each payment will amount to MXN 0.241875 per share, or MXN 1.935 per KOF UBL unit. This provides investors with clear visibility on expected cash distributions through next year. See our latest analysis for Coca-Cola FEMSA. de. The dividend...

Aflac (NYSE:AFL) has introduced a hybrid term life and long term care rider aimed at aging U.S. consumers. The company is responding to growing long term care needs with a product that blends life insurance coverage and potential long term care benefits. Activist shareholder John Chevedden has filed a proposal urging Aflac to separate the Chairman and CEO roles. Aflac’s board is recommending shareholders vote against the governance proposal at the upcoming annual meeting. Aflac, trading...

RBC Capital has initiated coverage of Weatherford International (WFRD) with a positive view, citing peer leading cash generation, strong returns, and what it sees as an attractive valuation during current industry supply disruptions. See our latest analysis for Weatherford International. Weatherford International’s share price has been volatile recently, with a 9.63% 7 day share price return offsetting a 10.22% 30 day share price decline. Its 1 year total shareholder return of 78.30% and very...

PayPal Holdings (PYPL) sits at the intersection of fresh regulatory pressure and product expansion, as US regulators question its account practices while the company rolls out its PYUSD stablecoin across 70 markets worldwide. See our latest analysis for PayPal Holdings. The recent mix of regulatory warnings and new product launches has not yet translated into share price strength. A 90 day share price return of 24.63% decline and a 1 year total shareholder return of 34.01% decline point to...

Recently, CF Industries Holdings was removed from the FTSE All-World Index and urged shareholders to vote against a proposal limiting large executive severance packages at its upcoming April 28, 2026 annual meeting. Together with an upbeat analyst reassessment tied to tight nitrogen markets, these developments highlight how corporate governance choices intersect with CF Industries’ positioning in global fertilizer and low-carbon ammonia markets. We’ll now examine how CF Industries’ index...

If you are wondering whether West Pharmaceutical Services is priced fairly or carrying a premium, the recent share performance gives an important starting clue before looking at the numbers behind it. The stock last closed at US$248.12, with returns of 3.2% over 7 days, 1.1% over 30 days, a 10.2% decline year to date, and a 10.1% gain over 1 year. This combination paints a mixed picture of recent sentiment. Recent coverage on West Pharmaceutical Services has focused on its role in...

Without a specific news announcement driving attention today, MSC Industrial Direct (MSM) still gives investors a lot to consider, including its US$3.8b in revenue and its recent mixed share price moves. See our latest analysis for MSC Industrial Direct. The recent 1-day share price decline of 2.63% to US$89.48 follows a 7-day gain of 2.99% and a 1-year total shareholder return of 15.93%, pointing to steady long-term momentum despite some near-term volatility. If this kind of industrial...

Cloudflare stock snapshot and recent performance Cloudflare (NET) shares recently closed at US$210.13, with the stock showing a 3.6% decline over the past day and a 5.1% decline over the past week, while remaining positive over the month and past 3 months. See our latest analysis for Cloudflare. While Cloudflare’s share price has slipped in the past week, its 28.3% 1 month share price return and 77.2% 1 year total shareholder return suggest momentum has been strong over both shorter and...

In March 2026, several banks, including Bernstein and JPMorgan, updated their views on Roivant Sciences after a global settlement with Moderna over lipid nanoparticle technology. These analyst actions suggest the settlement is shifting attention away from legal risk and toward Roivant’s upcoming clinical trial milestones in pulmonary hypertension and non-infectious uveitis. We’ll now examine how the Moderna settlement, seen as clearing a legal overhang, may influence Roivant’s existing...

FMC (FMC) has drawn attention after reporting annual revenue of US$3.47b alongside a net loss of US$2.20b. This has prompted investors to reassess how the agricultural sciences group is currently being valued. See our latest analysis for FMC. Despite the headline net loss, FMC’s recent share price performance has been firmer, with a 12.8% 1 month share price return and a 15.5% 3 month share price return. However, the 1 year total shareholder return of 61.4% remains deeply negative. If you are...

Transcosmos announced it had helped Wacoal roll out Shopify-based e-commerce sites across Vietnam, Hong Kong and Singapore, with Malaysia and the Philippines to follow, using a centralized Shopify Plus master site to cut costs and simplify local customization. This rollout highlights how Shopify’s platform is being used to standardize global brand governance while still enabling locally tailored operations, boosting efficiency and conversion for enterprise retailers in Asia. We’ll now...

Venture Global (NYSE:VG) and Edison resolved their arbitration related to the Calcasieu Pass LNG project. The settlement includes a commercial agreement to supply additional LNG cargoes into Europe, with a focus on Italy. The resolution ends a prolonged legal dispute and adjusts the future commercial relationship between the two companies. Venture Global, an LNG exporter with a growing presence in transatlantic gas trade, now has one less legal overhang tied to its Calcasieu Pass project...

Crown Holdings (NYSE:CCK) has appointed Dr. John M. Rost as Executive Vice President and Chief Operating Officer, Asia Pacific and Transit Packaging. The company also received a shareholder proposal seeking the right for investors to act by written consent, ahead of its annual meeting. Crown Holdings, trading at $101.69, is drawing attention as it reshapes senior leadership around its Asia Pacific and Transit Packaging operations. The stock shows a 29.1% return over 3 years and a 14.5%...